Bolondi, L. and Tak, W. Y. and Gasbarrini, A. and Santoro, A. and Colombo, M. and Lim, H. Y. and Mazzaferro, V. and Wiest, R. and Reig, M. and Bruix, J. (2011) Phase II Safety Study of the Oral Multikinase Inhibitor Regorafenib (BAY 73-4506) as Second-line Therapy in Patients With Hepatocellular Carcinoma. EUROPEAN JOURNAL OF CANCER, 47 (Suppl1). S464. ISSN 0959-8049
Full text not available from this repository.Item Type: | Article |
---|---|
Subjects: | 600 Technology > 610 Medical sciences Medicine |
Divisions: | Medicine > Lehrstuhl für Innere Medizin I |
Depositing User: | Petra Gürster |
Date Deposited: | 05 May 2020 07:30 |
Last Modified: | 05 May 2020 07:30 |
URI: | https://pred.uni-regensburg.de/id/eprint/20228 |
Actions (login required)
View Item |